Editorial
Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1831-S1834
.
(29 September 2019)
PDA clipping by video-assisted thoracoscopic surgery
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1835-S1836
.
(29 September 2019)
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1837-S1840
.
(29 September 2019)
Bridging the gap: how do we improve long-term survival of locally-advanced esophageal cancer patients?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1841-S1843
.
(29 September 2019)
Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1844-S1846
.
(29 September 2019)
Impact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1847-S1851
.
(29 September 2019)
Does osimertinib treatment discriminate young patients?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1852-S1854
.
(29 September 2019)
Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1855-S1860
.
(29 September 2019)
Devil is in the detail—how to critically analyze studies designed to assess effectiveness of topical antibiotics in preventing sternal wound infections?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1861-S1864
.
(29 September 2019)
Editorial Commentary
Autopsy and clinical discrepancies in patients undergoing extracorporeal membrane oxygenation: a case series—a step towards understanding “Why”?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1865-S1868
.
(29 September 2019)
Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1869-S1873
.
(29 September 2019)
Optimal postoperative surveillance strategy in patients undergoing neoadjuvant chemoradiotherapy followed by surgery for esophageal carcinoma
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1874-S1876
.
(29 September 2019)
Hyperprogressive disease with immunotherapy: new directions
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1877-S1880
.
(29 September 2019)
Spread through air spaces in non-small cell lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1881-S1884
.
(29 September 2019)
Is no drain after thoracoscopic major resection for cancer acceptable?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1885-S1887
.
(29 September 2019)
Expanding the pool: the use of hepatitis C RNA positive organs in lung transplantation
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1888-S1890
.
(29 September 2019)
Preoperative variables for predicting prolonged air leak following pulmonary resection
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1891-S1893
.
(29 September 2019)
Challenge for establishment of international benchmarks for complications associated with esophagectomy
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1894-S1896
.
(29 September 2019)
Safety of perioperative low dose aspirin therapy in major lung resection
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1897-S1899
.
(29 September 2019)
No drain policy for “ultimate” enhanced recovery after surgery
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1900-S1902
.
(29 September 2019)
Scar modification for polymorphic ventricular tachycardia and ventricular fibrillation: hope beyond trigger ablation?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1903-S1905
.
(29 September 2019)
Blood tumor mutational burden: are we ready for clinical implementation?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1906-S1908
.
(29 September 2019)
Local consolidative therapy in metastatic non-small cell lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1909-S1912
.
(29 September 2019)
Preoperative treatment of anemia—could an ultra-short-term multimodal approach be beneficial for patients undergoing lung surgery?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1913-S1915
.
(29 September 2019)
Optimal lung cancer screening intervals following a negative low-dose computed tomography result
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1916-S1918
.
(29 September 2019)
The inadvertent compounding of misconceptions regarding the surgical treatment of atrial fibrillation in mitral valve patients
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1919-S1922
.
(29 September 2019)
Potential advantage of digital drainage systems using a low-suction approach after video-assisted thoracoscopic surgery lobectomy
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1923-S1924
.
(29 September 2019)
The prospective database on thymic epithelial tumours from the European Continent
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1925-S1926
.
(29 September 2019)
Increasing T stage is associated with the need for more extensive lymph node assessment in clinical stage I non-small cell lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1927-S1929
.
(29 September 2019)
What you do not know, you do not recognize…and you do not improve future patient care…particularly in extracorporeal life support (ECLS) patients
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1930-S1934
.
(29 September 2019)
Hybrid minimally invasive esophagectomy for esophageal cancer: less is more
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1935-S1937
.
(29 September 2019)
Predicting spread through air spaces (STAS) preoperatively: can imaging help?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1938-S1941
.
(29 September 2019)
Expanding the donor pool for lung transplantation using HCV-positive donors
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1942-S1946
.
(29 September 2019)
Role of chest tube drainage in physical function after thoracoscopic lung resection
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1947-S1950
.
(29 September 2019)
Hybrid esophagectomy: the best of both worlds
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1951-S1953
.
(29 September 2019)
Minimally invasive esophagectomy—behind patient-centered learning curves
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1954-S1956
.
(29 September 2019)
PEEP titration guided by transpulmonary pressure: lessons from a negative trial
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1957-S1962
.
(29 September 2019)
KEYNOTE-042 and the role for single agent pembrolizumab in patients with PD-L1 tumor proportion score 1–49%
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1963-S1965
.
(29 September 2019)
Transcatheter edge-to-edge mitral valve repair in functional mitral regurgitation: patient selection according to MITRA-FR and COAPT
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1966-S1968
.
(29 September 2019)
Lactate guided resuscitation—nothing is more dangerous than conscientious foolishness
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1969-S1972
.
(29 September 2019)
A new approach to predicting risk for N2 disease in non-small cell lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1973-S1975
.
(29 September 2019)
Prolonged air leak after pulmonary lobectomy
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1976-S1978
.
(29 September 2019)
What did the first meta-analysis of tumor spread through air spaces (STAS) bring to light?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1979-S1981
.
(29 September 2019)
Prolonged air leaks after vats lobectomy: do we need another risk score?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1982-S1985
.
(29 September 2019)
Radical consolidative treatments a hope for patients with oligometastatic non-small cell lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1986-S1989
.
(29 September 2019)
Intratumoral lymph vessel invasion as a predictive risk factor for nodal metastasis in non-small cell lung cancer: should L-1 status obligate adjuvant chemotherapy?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1990-S1991
.
(29 September 2019)
Demographic ageing and its influence on current lung transplant practice
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1992-S1994
.
(29 September 2019)
Searching for an arrow hitting two targets: the time to evaluate long-term outcomes of video-assisted thoracoscopic surgery lobectomy for early-stage lung cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1995-S1998
.
(29 September 2019)
Less is more: the benefits of low suction for digital pleural drainage devices after pulmonary resection
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S1999-S2001
.
(29 September 2019)
Importance of intraoperative fluid management
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2002-S2004
.
(29 September 2019)
Thymoma: does tumor size matter?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2005-S2007
.
(29 September 2019)
Expanding the knowledge of oligometastatic disease—but uncertainties remain significant
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2008-S2011
.
(29 September 2019)
Positive-end expiratory pressure titration and transpulmonary pressure: the EPVENT 2 trial
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2012-S2017
.
(29 September 2019)
Pancreatic PCSK9 and its involvement in diabetes
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2018-S2022
.
(29 September 2019)
The radical approach to the oligometastatic not small cell lung cancer patient: which? how? when? where?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2023-S2025
.
(29 September 2019)
Letter to the Editor
Chest ultrasound: enhanced recovery after surgery (ERAS) best friend in general thoracic surgery
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2026-S2027
.
(29 September 2019)
Is chest ultrasonography an essential tool for the modern thoracic surgeon?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2028-S2029
.
(29 September 2019)
Chest ultrasound versatility in routinary to complicated cases: our perspective
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2030-S2031
.
(29 September 2019)
Sex differences in the development of upper airway morphology: is this the new kid on the block?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2032-S2033
.
(29 September 2019)
Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2034-S2035
.
(29 September 2019)
Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2036-S2038
.
(29 September 2019)
Chest ultrasound in post-operative management: the needed to rethink our perspective?
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2039-S2040
.
(29 September 2019)
Pathologic complete response is not equivalent to cure in esophageal cancer
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2041-S2042
.
(29 September 2019)
Heterogeneity of stage IIIA leads to difficulty in determining optimal treatment
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2043-S2045
.
(29 September 2019)
The tightrope walk between temporary and permanent mechanical circulatory support
Journal of Thoracic Disease
2019;
11
(Suppl 15)
:S2046-S2047
.
(29 September 2019)
Disclosure:
The supplement was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding.
